Clinical Trials Directory

Trials / Unknown

UnknownNCT01892072

VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators study the VEGF signaling in HCC cell lines and its mechanism in HCC growth, proliferation and apoptosis.

Detailed description

Several studies have documented the elevated expression of VEGF, VEGFR1 and VEGFR2 in HCC cell lines and tumor tissues. Another study observed a sequential elevation of VEGF in low-grade dysplasia, high-grade dysplasia and early stage HCC. Clinical analyses have discovered the high expression of VEGF is correlated with tumor progression, vascular invasion, distal metastasis and poor prognosis. However, few studies have been conducted to investigate the VEGF signaling in HCC cells and its possible mechanism in regulating HCC growth.Therefore,we try to clarify the mechanism of VEGF signal in HCC growth,proliferation and apoptosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgical treatmentall the patients in the study must have been treated by the surgery at the first time and have been confirmed as 'complete section' by the post-surgery radiological image.

Timeline

Start date
2012-10-01
Primary completion
2013-10-01
Completion
2014-03-01
First posted
2013-07-03
Last updated
2013-07-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01892072. Inclusion in this directory is not an endorsement.